Dyne Therapeutics
Approach: antibody-oligonucleotide conjugates
Status: Preclinical
Section of Dyne's website discussing myotonic dystrophy
Video on Dyne's website explaining its technology
Article on Dyne's technology
Press Release on Dyne's launch
April 3, 2019 Endpoints article on Dyne launch
June 13, 2019 Press Release: Dyne Therapeutics Presents Nonhuman Primate Proof of Concept Data on FORCE™ Therapeutic Platform at International Myotonic Dystrophy Consortium Meeting (IDMC-12)
September 14, 2019 Presentation at Myotonic conference (starts at 40:30)
October 2019 abstract presented at World Muscle Society conference